Pharma Stocks
-
Sun Pharma Advanced Research Company Surges with Unprecedented Buying Interest
Exceptional Market Activity and Price Movement On 2 December 2025, Sun Pharma Advanced Research Company Ltd (SPARC) demonstrated remarkable market…
Read More » -
NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21
NRx Pharmaceuticals, Inc. WILMINGTON, Del., Dec. 01, 2025 (GLOBE NEWSWIRE) — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, the “Company”, “NRx”), a…
Read More » -
Pharma stock with revenue growth guidance of 350% to add to your watchlist
This Pharma stock, is engaged in manufacturing high‑purity pharmaceutical intermediates and active pharmaceutical ingredients used by pharma, nutraceutical, personal care,…
Read More » -
Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Open Interest and Volume Dynamics Recent data reveals that Mankind Pharma’s open interest (OI) in derivatives has expanded by 1,427…
Read More » -
Sun Pharma and 2 other Nifty 500 stocks with golden crossover to keep on your radar
A golden crossover is a widely recognized bullish signal in the stock market, indicating a potential upward trend. It occurs…
Read More » -
A Fresh Look at Ascendis Pharma (ASND) Valuation Following FDA Extension for TransCon CNP Review
Ascendis Pharma (NasdaqGS:ASND) recently shared that the FDA has extended its review timeline for TransCon CNP by three months because…
Read More » -
Amneal Pharmaceuticals, Inc.’s (NASDAQ:AMRX) Price Is Right But Growth Is Lacking After Shares Rocket 25%
Despite an already strong run, Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) shares have been powering on, with a gain of 25% in…
Read More » -
The “pharma reversal”: 2 stocks breaking out for a 2026 rally – Stock Insights News
The Nifty50 gained over 10% year to date vs Nifty Pharma delivered -2.36%, due to global uncertainty around U.S. tariff…
Read More » -
Insiders Of Recce Pharmaceuticals Are Up 73% On Their AU$6.19m Purchase
Last week, Recce Pharmaceuticals Ltd (ASX:RCE) insiders, who had purchased shares in the previous 12 months were rewarded handsomely. The…
Read More » -
Does Eli Lilly’s Rally Signal a Better Value After Its Weight-Loss Drug Breakthrough?
Ever wondered if Eli Lilly’s massive popularity actually means it is a good value right now? You are not alone.…
Read More »